Mithra CDMO
Bridging expertise for successful pharmaceutical development
To forge alliances with life science partners to accelerate co-creation for the medical community
A pharmaceutical ecosystem
The Mithra CDMO open platform is accessible to partners willing to leverage our technological know-how and capabilities across the drug life-cycle from proof of concept to commercialization : a pharmaceutical ecosystem
An integrated R&D and manufacturing platform
Specialized in Polymer technology (intra uterine systems, biocompatible rings, implants), sterile injectables and hormonal tableting, Mithra CDMO is a unique integrated R&D and manufacturing platform.
Your business partner for innovation
Mithra CDMO ambition is to become your business partner for innovation offering a wide range of services: pharmaceutical development, clinical supply manufacturing capabilities, stability studies, contract manufacturing, logistics and supply chain, quality assurance and regulatory support.
Ideally located at the heart of Europe
Mithra CDMO is your seamless and intermodal connectivity location:
- Optimal motorway network (intersection of the E25, E40 and E42 motorways)
- Rail network with a high-speed railway station
- Liege Airport (7th largest cargo airport in Europe)
- The Port of Liege (3rd biggest river port in Europe) and the multimodal plateform Liège Trilogiport
Our 4 competitive advantages
1. Flexibility: small (pilot, clinical) to medium batch sizes
2. End-to-end services on one site (from development to commercial manufacturing)
3. State-of-the-art manufacturing facility and equipments
4. Able to handle special and high potent products
Overview
- 15,000 m² facilities in Liège (Belgium)
- 55,000 m² land
- 3 production units: polymeric forms, sterile injectables, hormonal tablets
- Dedicated R&D and production areas
- Full drug development services
- Pilot, clinical & commercial batches
- GMP Standards compliance (EMA / FDA)
To learn more about Mithra Pharmaceuticals,
please visit our corporate website: www.mithra.com